1590 studies found for:    "Liver Neoplasms"
Show Display Options
Rank Status Study
21 Completed A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Conditions: Liver Neoplasms;   Neoplasm Metastasis
Interventions: Procedure: Isolated hepatic portal and arterial perfusion;   Drug: Melphalan
22 Completed A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
Conditions: Colorectal Neoplasm;   Liver Neoplasm;   Neoplasm Metastasis
Interventions: Drug: Melphalan;   Drug: Floxuridine;   Drug: Leucovorin
23 Recruiting 4D Phase Contrast MR: Hypertrophy in Liver Cancer
Conditions: Liver Cancer;   Cancer of the Liver
Interventions: Device: 4Dimensional Phase Contrast Magnetic Resonance Angiography;   Procedure: Portal vein embolization
24 Terminated Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
Condition: Liver Tumors
Intervention: Drug: Definity®
25 Completed IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Conditions: Cancer of the Liver;   Liver Cancer;   Hepatoma;   Liver Neoplasms;   Biliary Cancer
Intervention: Biological: Salmonella typhimurium
26 Completed Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer
Intervention: Procedure: Radiofrequency Ablation
27 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
28 Completed Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Conditions: Colorectal Cancer;   Islet Cell Tumor;   Liver Cancer;   Metastatic Cancer;   Neuroendocrine Carcinoma
Interventions: Drug: isolated perfusion;   Drug: melphalan;   Procedure: conventional surgery
29 Withdrawn Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Condition: Liver Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: proteomic profiling;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: medical chart review
30 Completed Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
Condition: Liver Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: thalidomide
31 Terminated
Has Results
Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: sunitinib malate;   Other: laboratory biomarker analysis;   Procedure: hepatic artery embolization;   Procedure: quality-of-life assessment
32 Completed Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer
Interventions: Drug: isolated perfusion;   Drug: melphalan
33 Completed A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
Conditions: Carcinoma, Hepatic Cell;   Liver Cancer
Intervention: Drug: pazopanib
34 Not yet recruiting Phase I Trial of Radiation Therapy in Patients With Liver Cancers and Impaired Liver Function
Conditions: Liver Cancer;   Impaired Liver Function
Interventions: Radiation: Radiation Therapy;   Drug: Chemotherapy;   Behavioral: Questionnaire
35 Completed Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases
Conditions: Liver Cancer;   Metastatic Cancer
Intervention: Procedure: cryosurgery
36 Terminated Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients
Conditions: Liver Neoplasms;   Liver Cirrhosis;   Carcinoma, Hepatocellular;   Recurrence;   Neoplasm Recurrence, Local
Intervention: Drug: Oxaliplatin, gemcitabine, cisplatin, lipiodol
37 Terminated
Has Results
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: computed tomography;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Procedure: radiofrequency ablation;   Procedure: radionuclide imaging;   Procedure: ultrasound imaging;   Radiation: fludeoxyglucose F 18 (FDG-PET);   Radiation: gadopentetate dimeglumine
38 Recruiting Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Lipiodol
39 Completed
Has Results
An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
Conditions: Liver Neoplasms;   Unresectable Hepatocellular Carcinoma
Intervention: Drug: Sunitinib (SU011248)
40 Completed Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Condition: Liver Cancer
Interventions: Drug: alvocidib;   Drug: irinotecan hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years